TGTX
Tg Therapeutics Inc Earnings
$43.86
Earnings Summary
Revenue | $108.19Mn |
Net Profits | $23.33Mn |
Net Profit Margins | 21.57% |
Tg Therapeutics Inc’s revenue jumped 146.04% since last year same period to $108.19Mn in the Q4 2024. On a quarterly growth basis, Tg Therapeutics Inc has generated 28.98% jump in its revenue since last 3-months.
Tg Therapeutics Inc’s net profit jumped 261.84% since last year same period to $23.33Mn in the Q4 2024. On a quarterly growth basis, Tg Therapeutics Inc has generated 501.31% jump in its net profits since last 3-months.
Tg Therapeutics Inc’s net profit margin jumped 165.78% since last year same period to 21.57% in the Q4 2024. On a quarterly growth basis, Tg Therapeutics Inc has generated 366.22% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.09 |
EPS Estimate Current Year | 0.09 |
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.09 - a 200% jump from last quarter’s estimates.
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.09.
Key Ratios
Earning Per Share (EPS) | 0.15 |
Tg Therapeutics Inc’s earning per share (EPS) jumped 250% since last year same period to 0.15 in the Q4 2024. This indicates that the Tg Therapeutics Inc has generated 250% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-06 | -0.04 | -0.07 | -75% |
2025-03-03 | 0.09 | 0.15 | 66.67% |
2024-08-09 | -0.05 | 0.04 | 180% |
2024-11-07 | 0.03 | 0.02 | -33.33% |
